Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Alimentary Pharmacology & Therapeutics
|
February 22, 2007
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation
T Poynard, P Halfon, L Castera, et al.
Clinical and Experimental Immunology
|
August 11, 1998
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group
P Cacoub, L Musset, P Hausfater, et al.
Alimentary Pharmacology & Therapeutics
|
September 5, 2007
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C
R Morra, M Munteanu, P Bedossa, et al.
Journal of Clinical Pathology
|
November 24, 1999
Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring
F Imbert-Bismut, F Charlotte, B Turlin, et al.
La Revue De Medecine Interne
|
January 26, 2020
[Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review]
F Maillet, M Pineton De Chambrun, Q Monzani, et al.
Transgenic Research
|
December 22, 1998
Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene
J L Cohen, O Boyer, B Salomon, et al.
Arthritis and Rheumatism
|
October 11, 2001
Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia
P Cacoub, C Renou, G Kerr, et al.
Hepatology (Baltimore, Md.)
|
March 21, 1998
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
P Mathurin, J Moussalli, J F Cadranel, et al.
La Revue De Medecine Interne
|
November 26, 2016
[Neurosarcoidosis: Diagnosis and therapeutic issues]
F Cohen Aubart, D Galanaud, J Haroche, et al.
Leukemia & Lymphoma
|
May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients
C Soussain, B Souleau, J Gabarre, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Alimentary Pharmacology & Therapeutics
|
February 22, 2007
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation
T Poynard, P Halfon, L Castera, et al.
Clinical and Experimental Immunology
|
August 11, 1998
No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group
P Cacoub, L Musset, P Hausfater, et al.
Alimentary Pharmacology & Therapeutics
|
September 5, 2007
Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C
R Morra, M Munteanu, P Bedossa, et al.
Journal of Clinical Pathology
|
November 24, 1999
Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring
F Imbert-Bismut, F Charlotte, B Turlin, et al.
La Revue De Medecine Interne
|
January 26, 2020
[Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review]
F Maillet, M Pineton De Chambrun, Q Monzani, et al.
Transgenic Research
|
December 22, 1998
Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene
J L Cohen, O Boyer, B Salomon, et al.
Arthritis and Rheumatism
|
October 11, 2001
Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia
P Cacoub, C Renou, G Kerr, et al.
Hepatology (Baltimore, Md.)
|
March 21, 1998
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
P Mathurin, J Moussalli, J F Cadranel, et al.
La Revue De Medecine Interne
|
November 26, 2016
[Neurosarcoidosis: Diagnosis and therapeutic issues]
F Cohen Aubart, D Galanaud, J Haroche, et al.
Leukemia & Lymphoma
|
May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patients
C Soussain, B Souleau, J Gabarre, et al.
Page
of 11